Learning Objective 1:Recognize the role of adjuvant systemic therapy for resected lung cancer.

Learning Objective 2:Understand some of the unique toxicities of the small molecule tyrosine kinase inhibitors in use for lung cancer treatment.

Learning Objective 3:Appreciate the role of immune checkpoint inhibitors in lung cancer management